This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interleukin-13 (IL13), C-His
Product Overview
BioVenic's Recombinant Equine Interleukin-13 (IL13), C-His is a recombinant protein expressed from Yeast. Its predicted molecular weight is 13.9 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Equine Interleukin-13 (IL13) is a cytokine critical for regulating immune responses, particularly in Th2 cell-mediated reactions. It plays a pivotal role in modulating inflammation and allergy, and influences B-cell functions. In equine veterinary medicine, IL13 is significant for managing respiratory diseases, allergies, and immune-mediated conditions in horses.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquot as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months. Avoid repeated freezing and thawing.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimise freeze-thaw cycles.